HRD is associated with increased immunophenotype markers including TMB-high, increased CD3+ and CD8+ TILs, and increased levels of PD-1/PD-L1 compared to HRP tumors [51,61,62]. This evidence concerns the gene CD274 and hypoparathyroidism-retardation-dysmorphism syndrome.